Crystal Structure of a Phosphoinositide Phosphatase, MTMR2: Insights into Myotubular Myopathy and Charcot-Marie-Tooth Syndrome

Molecular Cell

Volumn 12, Issue 6, 2003, Pages 1391-1402

  Begley, Michael J ^a,b   Taylor, Gregory S ^a,b   Kim, Soo A ^a   Veine, Donna M ^a   Dixon, Jack E ^a,b   Stuckey, Jeanne A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MYOTUBULARIN RELATED PROTEIN 2; PHOSPHATASE; PLECKSTRIN; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CENTRONUCLEAR MYOPATHY; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MISSENSE MUTATION; MOLECULAR INTERACTION; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

EID: 0346156077     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00486-6     Document Type: Article

References (70)

1. Abrahams J.P., Leslie A.G.W. Methods used in the structure determination of bovine F-1 ATPase. Acta Crystallogr. D. 52:1996;30-42.
2. Appel S., Reichwald K., Zimmermann W., Reis A., Rosenthal A., Hennies H.C. Identification and localization of a new human myotubularin-related protein gene, MTMR8, on 8p22-p23. Genomics. 75:2001;6-8.
3. Berger P., Bonneick S., Willi S., Wymann M., Suter U. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 11:2002;1569-1579.
4. Biancalana V., Caron O., Gallati S., Baas F., Kress W., Novelli G., D'Apice M.R., Lagier-Tourenne C., Buj-Bello A., Romero N.B.et al. Characterization of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum. Genet. 112:2003;135-142.
5. Blomberg N., Baraldi E., Nilges M., Saraste M. The PH superfold. a structural scaffold for multiple functions Trends Biochem. Sci. 24:1999;441-445.
6. Blondeau F., Laporte J., Bodin S., Superti-Furga G., Payrastre B., Mandel J.-L. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet. 9:2000;2223-2229.
7. Bolino A., Brancolini V., Bono F., Bruni A., Gambardella A., Romeo G., Quattrone A., Devoto M. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum. Mol. Genet. 5:1996;1051-1054.
8. Bolino A., Muglia M., Conforti F.L., LeGuern E., Salih M.A.M., Georgiou D.-M., Christodoulou K., Hausmanowa-Petrusewicz I., Mandich P., Schenone A.et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25:2000;17-19.
9. Bolino A., Lonie L.J., Zimmer M., Boerkoel C.F., Takashima H., Monaco A.P., Lupski J.R. Denaturing high-performance liquid chromatography of the myotubularin-related 2 gene (MTMR2) in unrelated patients with Charcot-Marie-Tooth disease suggests a low frequency of mutation in inherited neuropathy. Neurogenetics. 3:2001;107-109.
10. phox bound to phosphatidylinositol 3-phosphate. Mol. Cell. 8:2001;829-839.
11. Brunger A.T., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system (CNS). a new software system for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
12. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt). a multifunctional mediator of phosphatidylinositol 3-kinase activation Biochem. J. 335:1998;1-13.
13. CCP4 Collaborative Computational Project, Number 4) The CCP4 suite. programs for protein crystallography Acta Crystallogr. D Ciol. Crystallogr. 50:1994;760-763.
14. Cui X., De Vivo I., Slany R., Miyamoto A., Firestein R., Cleary M.L. Association of SET domain and myotubularin-related proteins modulates growth control. Nat. Genet. 18:1998;331-337.
15. Denu J., Dixon J.E. Protein tyrosine phosphatases. mechanisms of catalysis and regulation Curr. Opin. Chem. Biol. 2:1998;633-641.
16. Denu J., Stuckey J.A., Saper M.A., Dixon J.E. Form and function in protein dephosphorylation. Cell. 87:1996;361-364.
17. De Vivo I., Cui X., Domen J., Cleary M.L. Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1. Proc. Natl. Acad. Sci. USA. 95:1998;9471-9476.
18. Doerks T., Strauss M., Brendel M., Bork P. GRAM, a novel domain in glucosyltransferases, myotubularins, and other putative membrane-associated proteins. Trends Biochem. Sci. 25:2000;483-485.
19. Doublie S. Preparation of selenomethionyl proteins for phase determination. Methods Enzymol. 276:1997;523-530.
20. Duan X., Hall J.A., Nikaido H., Quiocho F.A. Crystal structures of the maltodextrin/maltose-binding protein complexed with reduced oligosaccharides. flexibility of tertiary structure and ligand binding J. Mol. Biol. 306:2001;1115-1126.
21. Essen L.-O., Perisic O., Cheung R., Katan M., Williams R.L. Crystal structure of a mammalian phosphoinositide-specific phospholipase Cδ Nature. 380:1996;595-602.
22. Fauman E.B., Saper M.A. Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21:1996;413-417.
23. Firestein R., Cleary M.L. Pseudo-phosphatase Sbf1 contains an N-terminal GEF homology domain that modulates its growth regulatory properties. J. Cell Sci. 114:2001;2921-2927.
24. Firestein R., Cui X., Huie P., Cleary M.L. Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol. Cell. Biol. 20:2000;4900-4909.
25. Flex E., De Luca A., D' Apice M.R., Buccino A., Dallapiccola B., Novelli G. Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC). Neuromuscul. Disord. 12:2002;501-505.
26. Flint A.J., Tiganis T., Barford D., Tonks N.K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA. 94:1997;1680-1685.
27. Hammans S.R., Robinson D.O., Moutou C., Kennedy C.R., Dennis N.R., Hughes P.J., Ellison D.W. A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy. Neuromuscul. Disord. 10:2000;133-137.
28. Haslam R.J., Koide H.B., Hemmings B.A. Pleckstrin domain homology. Nature. 363:1993;309-310.
29. Hendrickson W.A. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science. 254:1991;51-58.
30. Herman G.E., Kopacz K., Zhao W., Mills P.L., Metzenberg A., Das S. Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. Hum. Mutat. 19:2002;114-121.
31. Holm L., Sander C. Dali. a network tool for protein structure comparison J. Mol. Biol. 233:1993;123-138.
32. Houlden H., King R.H.M., Wood N.W., Thomas P.K., Reilly M.M. Mutations in the 5′ region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain. 124:2001;907-915.
33. Jia Z., Barford D., Flint A.J., Tonks N.K. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science. 268:1995;1754-1758.
34. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
35. Kim S.-A., Taylor G.S., Torgersen K.M., Dixon J.E. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J. Biol. Chem. 277:2002;4526-4531.
36. Kim S.-A., Vacratsis P.O., Firestein R., Cleary M.L., Dixon J.E. Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl. Acad. Sci. USA. 100:2003;4492-4497.
37. Laporte J., Hu L.J., Kretz C., Mandel J.-L., Kioschis P., Coy J.F., Kluack S.M., Poustka A., Dahl N. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:1996;175-182.
38. Laporte J., Biancalana V., Tanner S.M., Kress W., Schneider V., Wallgren-Pettersson C., Herger F., Buj-Bello A., Blondeau F., Liechti-Gallati S.et al. MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat. 15:2000;393-409.
39. Laporte J., Blondeau F., Buj-Bello A., Mandel J.-L. The myotubularin family. from genetic disease to phosphoinositide metabolism Trends Genet. 17:2001;221-228.
40. Laporte J., Blondeau F., Gansmuller A., Lutz Y., Vonesch J.-L., Mandel J.-L. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J. Cell Sci. 115:2002;3105-3117.
41. Lee J.-O., Yang H., Georgescu M.-M., Di Cristofano A., Maehama T., Shi Y., Dixon J.E., Pandolfi P., Pavletich N. Crystal structure of the PTEN tumor suppressor. implications for its phosphoinositide phosphatase activity and membrane association Cell. 99:1999;323-334.
42. Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57:1997;2124-2129.
43. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.L., Puc J., Miliaresis C., Rodgers L., McCombie R.et al. PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
44. Lupas A. Prediction and analysis of coiled-coil structures. Methods Enzymol. 266:1996;513-525.
45. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:1998;13375-13378.
46. Maehama T., Taylor G.S., Slama J.T., Dixon J.E. A sensitive assay for phosphoinositide phosphatases. Anal. Biochem. 279:2000;248-250.
47. Maehama T., Taylor G.S., Dixon J.E. PTEN and myotubularin. novel phosphoinositide phosphatases Annu. Rev. Biochem. 70:2001;247-279.
48. Mayer B.J., Ren R., Clark K.L., Baltimore D. A putative modular domain present in diverse signaling molecules. Cell. 73:1993;629-630.
49. McCain D.F., Catrina I.E., Hengge A.C., Zhang Z.-Y. The catalytic mechanism of cdc25a phosphatase. J. Biol. Chem. 277:2002;11190-11200.
50. Michael S.F. Mutagenesis by incorporation of a phosphorylated oligo during PCR amplification. Biotechniques. 16:1994;410-412.
51. Mochizuki, Y., and Majerus, P.W. (2003). Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl. Acad. Sci. USA Jul 30, epub ahead of print.
52. Nandurkar H.H., Caldwell K.K., Whisstock J.C., Layton M.J., Gaudet E.A., Norris F.A., Majerus P.W., Mitchell C.A. Characterization of an adaptor subunit to a phosphatidylinositol (3)P 3-phosphatase. Identification of a myotubularin-related protein lacking catalytic activity Proc. Natl. Acad. Sci. USA. 98:2001;9499-9504.
53. Nandurkar H.H., Layton M., Laporte J., Selan C., Corcoran L., Caldwell K.K., Mochizuki Y., Majerus P.W., Mitchell C.A. Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl. Acad. Sci. USA. 100:2003;8660-8665.
54. Nelis E., Erdem S., Tan E., Lofgren A., Ceuterick C., De Jonghe P., Van Broeckhoven C., Timmerman V., Topaloglu H. A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromuscul. Disord. 12:2002;869-873.
55. Oku M., Warnecke D., Noda T., Muller F., Heinz E., Mukaiyama H., Kato N., Sakai Y. Peroxisome degradation requires catalytically active sterol glucosyltransferase with a GRAM domain. EMBO J. 22:2003;3231-3241.
56. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
57. Rameh L.E., Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:1999;8347-8350.
58. Reynolds R.A., Yem A.W., Wolfe C.L., Deibel M.R. Jr., Chidester C.G., Watenpaugh K.D. Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J. Mol. Biol. 293:1999;559-568.
59. Schaletzky J., Dove S.K., Short B., Lorenzo O., Clague M.J., Barr F.A. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr. Biol. 13:2003;504-509.
60. Senderek J., Bergmann C., Weber S., Ketelsen U., Schorle H., Rudnik-Shoneborn S., Buttner R., Buchheim E., Zerres K. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12:2003;349-356.
61. Schultz J., Milpetz F., Bork P., Ponting C.P. SMART, a simple modular architecture research tool. Identification of signaling domains Proc. Natl. Acad. Sci. USA. 95:1998;5857-5864.
62. Spiro A.J., Shy G.M., Gonatas N.K. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch. Neurol. 14:1966;1-14.
63. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baugmard M.L., Hattier T., Davis T.et al. Identification of a candidate tumor suppressor gene MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15:1997;356-362.
64. Stuckey J.A., Schubert H.L., Fauman E.B., Zhang Z.-Y., Dixon J.E., Saper M.A. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate. Nature. 370:1994;571-575.
65. Taylor G.S., Maehama T., Dixon J.E. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. USA. 97:2000;8910-8915.
66. Walker D.M., Urbe S., Dove S.K., Tenza D., Raposo G., Clague M.J. Characterization of MTMR3, an inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11:2001;1600-1605.
67. Wishart M.J., Dixon J.E. Gathering STYX. phosphatase-like form predicts functions for unique protein-interaction domains Trends Biochem. Sci. 23:1998;301-306.
68. Wishart M.J., Taylor G.S., Slama J.T., Dixon J.E. PTEN and myotubularin phosphoinositide phosphatases. bringing bioinformatics to the lab bench Curr. Opin. Cell Biol. 13:2001;172-181.
69. Yuvaniyama J., Denu J.M., Dixon J.E., Saper M.A. Crystal structure of the dual specificity protein phosphatase VHR. Science. 272:1996;1328-1331.
70. Zhao R., Qi Y., Chen J., Zhao Z.J. FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphatidylinositol 3-phosphate. Exp. Cell Res. 265:2001;329-338.